These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 575493)

  • 1. The action of creatinol 0-phosphate on the inotropic effect of isoprenaline in isolated rat atria and in anesthetized dogs.
    Godfraind T; Ghysel-Burton J; Merlo L
    Arzneimittelforschung; 1979; 29(9a):1465-7. PubMed ID: 575493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of creatinol-O-phosphate on the contractility changes evoked by hypoxia and ischemia in rat isolated heart.
    Godfraind T; Saleh MM
    Arzneimittelforschung; 1984; 34(9):968-72. PubMed ID: 6542374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionic changes evoked by isoprenaline in rat hearts in vivo and in vitro and their reduction by creatinol O-phosphate.
    Godfraind T; Ghysel-Burton J; Sturbois X
    Arzneimittelforschung; 1979; 29(9a):1468-70. PubMed ID: 575494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of the reduction by creatinol O-phosphate of the myocardial lesions evoked by isoprenaline in the rat.
    Godfraind T; Sturbois X
    Arzneimittelforschung; 1979; 29(9a):1457-64. PubMed ID: 575492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective action of creatinol O-phosphate against serum CPK activity enhanced by isoprenaline in the rat.
    Marzo A; Ghirardi P
    Arzneimittelforschung; 1979; 29(9a):1471-3. PubMed ID: 575495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of creatinol O-phosphate on the isolated rabbit's atrium and on the rat's phrenic nerve diaphragm preparation].
    Ferrini R; Miragoli G
    Farmaco Sci; 1975 Nov; 30(11):912-6. PubMed ID: 1238289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevention by creatinol O-phosphate of myocardial lesions evoked by isoprenaline.
    Godfraind T; Sturbois X
    Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):288-97. PubMed ID: 573603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute clinical tolerance of creatinol O-phosphate.
    Melloni GF; Minoja GM; Lureti GF; Merlo L; Pamparana F; Brusoni B
    Arzneimittelforschung; 1979; 29(9a):1447-9. PubMed ID: 575490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of creatinol O-phosphate (COP) on some experimental arrhythmias in vitro and in vivo.
    Ferrini R; Miragoli G
    Arzneimittelforschung; 1979; 29(9a):1475-7. PubMed ID: 575497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and chemical properties of N- and O-phosphorylated derivatives of creatinol.
    Ferrari G; Casagrande C
    Arzneimittelforschung; 1979; 29(9a):1446-9. PubMed ID: 575489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of creatinol-O-phosphate on left ventricular function in coronary disease patients].
    Cucchini F; Colla B; Di Donato M; Visioli O
    Boll Soc Ital Cardiol; 1978; 23(3):527-32. PubMed ID: 572691
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of creatinol-O-phosphate (COP) on haemodynamics and cardiac metabolism in conscious and anaesthetized dogs.
    Marchetti G; Merlo L
    Arzneimittelforschung; 1978; 28(10):1708-11. PubMed ID: 582673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of creatinol O-phosphate on serum enzymes in acute myocardial infarction.
    Knippel M; Bana G; Pusterla GL
    Arzneimittelforschung; 1979; 29(9a):1480-2. PubMed ID: 575498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice.
    Ferrini R; Miragoli G
    Arzneimittelforschung; 1979; 29(9a):1473-4. PubMed ID: 575496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanism of the negative inotropic effect of alpha1-adrenoceptor agonists in rat isolated left atria after exposure to free radicals.
    Peters SL; Batink HD; Michel MC; Pfaffendorf M; van Zwieten PA
    Br J Pharmacol; 1998 Mar; 123(5):952-8. PubMed ID: 9535025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and toxicological properties of creatinol O-phosphate. A review.
    Marzo A; Ghirardi P
    Arzneimittelforschung; 1979; 29(9a):1449-52. PubMed ID: 395957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotropic and inotropic responses to ASL-7022 on isolated rat atria.
    Gende OA; Camilión de Hurtado MC
    Acta Physiol Pharmacol Latinoam; 1989; 39(2):119-26. PubMed ID: 2618750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.
    Inoue M; Hori M; Nakajima S; Kitakaze M; Fukunami M; Ishida Y; Abe H
    Arzneimittelforschung; 1984; 34(3A):355-9. PubMed ID: 6540088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.